BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33725899)

  • 1. A 10-year observational single-center study of retroperitoneal unicentric Castleman disease.
    Wang W; Dong D; Wen J; Li H
    Medicine (Baltimore); 2021 Mar; 100(10):e25088. PubMed ID: 33725899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
    Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
    Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of multiparameter
    Jiang Y; Hou G; Zhu Z; Huo L; Cheng W; Li F
    Sci Rep; 2020 Jul; 10(1):12887. PubMed ID: 32732920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature.
    Cheng JL; Cui J; Wang Y; Xu ZZ; Liu F; Liang SB; Tian H
    World J Gastroenterol; 2018 Sep; 24(34):3958-3964. PubMed ID: 30228787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperitoneal unicentric Castleman's disease with multiple lymph node involvement.
    Schulte KM; Sinha P; Talat N; Diaz-Cano S
    BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22696693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
    Wang P; Hou G; Li F; Cheng X
    Clin Nucl Med; 2021 Jun; 46(6):510-511. PubMed ID: 33939651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of characteristics of four patients with adrenal unicentric Castleman disease.
    Yu H; Wang Y; Li Y; Du J; Guo Q; Gu W; Lyu Z; Dou J; Mu Y; Zang L
    Front Endocrinol (Lausanne); 2023; 14():1181929. PubMed ID: 37265694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
    Luo Y; Wang L; Pan Q; Ma Y; Li F
    Clin Nucl Med; 2018 Jul; 43(7):551-552. PubMed ID: 29742598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
    J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal Castleman's disease: benign in the midst of malignancy.
    Jayant K; Agrawal S; Agrawal R
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24700042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 5-year-old boy with unicentric Castleman disease affecting the mesentery: utility of serum IL-6 level and (18)F-FDG PET for diagnosis.
    Toita N; Kawamura N; Hatano N; Takezaki S; Ohkura Y; Yamada M; Okano M; Okada T; Sasaki F; Kubota KC; Itoh T; Ariga T
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):693-5. PubMed ID: 19730402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castlemans disease - surgical treatment, case reports.
    Penka I; Kala Z; Zetelová A; Kunovsky L; Szturz P; Kren L; Mechl M; Rehak Z; Hanke I
    Rozhl Chir; 2016; 95(12):457-461. PubMed ID: 28182443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Large Retroperitoneal Mass in an Asymptomatic 22-Year-Old Man.
    Anderson B; Rangan A; Sweetser S
    Gastroenterology; 2017 Nov; 153(5):1200-1202. PubMed ID: 28843956
    [No Abstract]   [Full Text] [Related]  

  • 14.
    Fernández-Rodríguez P; Fernández López R; Acevedo Báñez I; Mohigefer Barrera J; Jiménez-Hoyuela García JM
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):222-223. PubMed ID: 31494704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.
    Hu S; Li Z; Wang H; Chen L; Ma Y; Zhu X; Li J; Dong R; Yao W; Dong C; Zhang H; Li K; Dong K; Zhai X
    Eur J Pediatr; 2023 Dec; 182(12):5519-5530. PubMed ID: 37782352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound and radiological features of abdominal unicentric castleman's disease: A case series study.
    Lv K; Zhao Y; Xu W; Zhang C; Huang P
    Medicine (Baltimore); 2020 May; 99(18):e20102. PubMed ID: 32358399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic Castleman Disease on FDG PET/CT.
    Li F; Xiao L; Cai H; Li L
    Clin Nucl Med; 2023 Jan; 48(1):71-72. PubMed ID: 35961369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castleman disease in the hilum liver mimicking the lymph node metastasis of hepatocellular carcinoma on 18F-FDG PET/CT: A case report.
    Hu Y; Liu Y; Shi H
    Medicine (Baltimore); 2018 Mar; 97(12):e9939. PubMed ID: 29561464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CARE-compliant article: Unicentric Castleman disease presenting as a retroperitoneal mass of the upper edge of the pancreas: A case report.
    Zhou YX; Ji Y; Wu S
    Medicine (Baltimore); 2020 Mar; 99(11):e19515. PubMed ID: 32176100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.